Comments
Zydus Cadila has received final approval from the US health regulator to market Acyclovir injection, used to treat infections caused by herpes virus, in the US market.
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Acyclovir Sodium injection, 500 mg/10 mL and 1,000 mg/20mL single-dosevials, Cadila Healthcare said in a BSE filing today.
The approved drug will be produced at the group’s formulation manufacturing facility at Moriya, Ahmedabad. The group now has nearly 216 approvals from the USFDA and so far filed 330 abbreviated new drug applications, Cadila Healthcare said.
Shares of Cadila Healthcare were trading up 2.31 per cent at Rs 401.30 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.